Interview with Andreas Djamwari, President Director, Soho Group
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
Providing value added products and caring for the customers are the key success factors of Metiska for over the past 26 years in the pharmaceutical industry.
Moving forward, they hope to push the boundaries of medicine in Indonesia, with a focus on high-end innovative products, unique formulations and value-added presentations.
They want to be the preferred partner of medical professionals, and we actively seek business partners who share the same vision of medicine as us.
Internally they constantly train their staff to become better professionals and will always welcome excited and motivated people to join the team.
http://www.metiska.co.id/home.html
HEAD OFFICE
Jl. Kebayoran Lama No. 557
Jakarta 12220, Indonesia
Telephone : +6221 720-2351 / 722-0076
Fax : +6221 725-0889
Email : info@metiska.co.id
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
IDS Distribution is part of an Asian, globe spanning Distribution Company. How does being part of a large, regionally specialized player help IDS Distribution in Indonesia? The company’s regional presence…
Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
